123 Main Street, New York, NY 10001
Investor Relations
Molecular Med Tri-Con 2022
Co-Diagnostics CEO Dwight Egan and Dr. Kirk Ririe, President of the Company's subsidiary, will be presenting in the conference's At-Home & Point-of-Care Diagnostics track on Monday, February 21 from 12:20 pm to 12:50 pm PST.
The presentation, titled "Co-Diagnostics' New Eikon PCR Platform," will be demonstrating how the Company's new platform technology is designed to provide inexpensive, fast, and accurate PCR results for at-home and point-of-care testing.
The following link to the presentation will be valid for one year:
